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Comparison of Blood Pressure Control and Left 
Ventricular Hypertrophy in Patients on Continuous 
Ambulatory Peritoneal Dialysis (CAPD) and Auto­
mated Peritoneal Dialysis (APD) 
This study aimed to investigate the influence of different peritoneal dialysis 
regimens on blood pressure control, the diurnal pattern of blood pressure and 
left ventricular hypertrophy in patients on peritoneal dialysis. Forty-four patients 
undergoing peritoneal dialysis were enrolled into the study. Patients were 
treated with different regimens of peritoneal dialysis: 26 patients on continuous 
ambulatory peritoneal dialysis (CAPD) and 18 patients on automated peritoneal 
dialysis (APD). All patients performed 24-hour ambulatory blood pressure 
monitoring (ABPM) and echocardiography. Echocardiography was performed 
for measurement of cardiac parameters and calculation of left ventricular mass 
index (LVMI). There were no significant differences in average of systolic and 
diastolic blood pressure during 24-hour, daytime, and nighttime between CAPD 
and APD groups. There were no significant differences in diurnal variation of 
blood pressure, systolic and diastolic blood pressure load, and LVMI between 
CAPD and APD groups. LVMI was associated with 24 hour systolic blood 
pressure load (r = 0.311, P < 0.05) and daytime systolic blood pressure load (r 
= 0.360, P < 0.05). In conclusion, this study found that there is no difference in 
blood pressure control, diurnal variation of blood pressure and left ventricular 
hypertrophy between CAPD and APD patients. The different peritoneal dialysis 
regimens might not influence blood pressure control and diurnal variation of 
blood pressure in patients on peritoneal dialysis.
Key Words: blood pressure monitoring, ambulatory; continuous ambulatory 
peritoneal dialysis (CAPD); automated peritoneal dialysis (APD); left ventricular 
mass index
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reasons for this, including factors related to peritoneal 
membrane transport characteristics and dialysis adequacy, 
lifestyle, and the increasing age
1). 
APD has been reported to have several advantages 
Introduction
Automated peritoneal dialysis (APD) is increasingly used 
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over continuous ambulatory peritoneal dialysis (CAPD) 
including lower incidence of peritonitis, better small solute 
clearances, reduced incidences of hernias, and better 
dialysis acceptability for workers
2-4). However, APD has 
potential disadvantages such as a more rapid loss of residual 
renal function, less sodium removal and more peritoneal 
protein loss
5-10). The short dwell times and less sodium 
and fluid removal of APD compared with CAPD seem to 
be associated with changes in hemodynamics and blood 
pressure control
7-9). 
Cardiovascular disease is the most common cause of 
morbidity and mortality in patients with end-stage renal 
disease (ESRD)
11). Hypertension in dialysis patients is an 
important risk factor for development of left ventricular 
hypertrophy (LVH) and for increased cardiovascular 
mortality. The main reason for hypertension in dialysis 
patients is volume overload
12, 13). Information on the 
compared ability of CAPD and APD to control blood 
pressure levels and prevent cardiovascular complications is 
very limited. 
The aim of this study is to investigate the influence of 
different peritoneal dialysis regimens on blood pressure 
control, the diurnal pattern of blood pressure and left 
ventricular hypertrophy in patients on peritoneal dialysis. 
Subjects and Method
A total of 44 stable patients undergoing peritoneal dialysis 
at Chungbuk National University Hospital for more than 
6 months were enrolled in this study. Patients were treated 
by different regimens of peritoneal dialysis: 26 patients on 
CAPD and 18 patients on APD. Patients' preference was 
the main reason to start APD. All patients performed 24-
hour ambulatory blood pressure monitoring (ABPM) and 
echocardiography. 
The ABPM device (90207 ABP Monitor; Spacelabs 
Healthcare Inc., Issaquah, Washington, USA) was employed 
for measurement of blood pressure using an oscillometric 
technique. The monitor was automatically programmed to 
inflate every 30 minutes from 7 AM until 11 PM (daytime). 
From 11 PM to 7 AM (nighttime), the device inflated every 
60 minutes. Mean 24-hour, daytime, and nighttime systolic 
BP and diastolic BP were derived from 24-hour ABPM as 
the average of measurements taken over the respective time 
period. ABPM recordings were downloaded, evaluated, 
and analyzed in a blinded manner at Spacelabs Healthcare. 
During the monitoring period, patients were instructed 
to attend to their usual activities, diet, and medications. 
Mean arterial pressure (MAP) was calculated as diastolic 
pressure plus one third of the difference between systolic 
and diastolic pressure. Diurnal blood pressure variation was 
characterized by an index calculated as the ratio between 
the blood pressure difference of daytime and nighttime 
and the daytime blood pressure value,  multiplied by 100. 
Non-dipper was defined as a reduction in nighttime systolic 
blood pressure or diastolic blood pressure less than 10% 
of the daytime blood pressure. Systolic blood pressure 
load and diastolic blood pressure load were defined as 
the percentage of readings higher than 135/85 mmHg for 
daytime blood pressure, and 125/75 mmHg for nighttime 
blood pressure. A blood pressure load greater than 30% 
was considered significant
14). 
Two-dimensional and M-mode echocardiography 
was performed using an iE 33 echocardiography sys-
tem (Phillips Medical Systems, Eindhoven, The Nethe-
lands). Measurements of end-systolic and end-diastolic 
left ventricular internal dimensions, end-diastolic 
interventricular septal thickness, end-diastolic posterior 
wall thickness, aortic root dimension, and left atrial 
dimension were made according to the American Society of 
Echocardiography guidelines
15). Criterias for LVH were left 
ventricular mass index (LVMI) 125 g/m
2 for males and 100 
g/m
2 for females. 
Left ventricular mass (LVM) was calculated by the 
formula derived by Devereux and Reichek
16) ;
LVM (g) = 1.04 × [(LVIDd + IVSd + LVPWd)
3 − 
(LVIDs)
3] − 13.6
where LVIDd is left ventricular end diastolic internal 
dimension, IVSd is interventricular septal thickness 
measured at end-diastole and LVPWd is posterior wall 18      JS Jang et al. • Blood Pressure Control and LVH in Patients on CAPD and APD 
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thickness. 
LVMI was standardized by dividing it to body surface 
area, which was calculated using DuBois formula
17).
The following data were collected for each patient: age, 
gender, body mass index, body weight, primary cause of 
ESRD, duration of hypertension and peritoneal dialysis, use 
of erythropoietin, hemoglobin, hematocrit, serum blood 
urea nitrogen, creatinine, albumin, calcium, and phosphate. 
Data of peritoneal dialysis therapy were collected, including 
peritoneal dialysis adequacy (weekly Kt/V and weekly 
creatinine clearance) and peritoneal equilibration test (PET). 
Routine PET was performed according to the method of 
Twardowski
18). Weekly Kt/V was calculated as 7 × (24-hour 
urea clearance/total body water), where total body water 
was estimated according to the formula of Watson et al.
19).
Weekly creatinine clearance was calculated as 7 × (24-
hour creatinine clearance/1.73 m
2 body surface area), where 
body surface was estimated by the method of DuBois
17). 
In this study, CAPD patients were treated with 4 
exchanges daily using 1,500–2,000 mL peritoneal dialysis 
solution containing 1.5%, 2.5%, or 4.25% dextrose for 
ultrafiltration as appropriate. For patients on APD, the 
cycler was programmed to deliver 4-5 cycles of 1,500–
2,000 mL peritoneal dialysis solution during the night. A 
final exchange of 1,000–1,500 mL was introduced and 
allowed to remain in the peritoneal cavity until the next 
cyclic exchange at night.
SPSS 12.0 for windows software was used for all 
statistical analysis (SPSS Inc, Chicago, IL, USA). Values are 
expressed as mean ± SD. The comparisons between groups 
were assessed by unpaired t-test or Wilcox singed-rank test. 
Chi-squre test was used for 2 × 2 contingency tables when 
appropriate for non-numeric data. Correlation between 
numerical parameters were analysed with Spearman’s 
correlation test. A P value of less than 0.05 was considered 
statistically significant.
Result
1. Patient characteristics 
This study group consisted of 44 patients on peritoneal 
dialysis (16 male, 28 female, mean age: 49.9 ± 13.2 years), 
including 26 patients on CAPD (9 male, 17 female, mean 
age: 52.8 ± 11.9 years) and 18 patients on APD (7 male, 11 
female, mean age: 45.7 ± 14.2 years). The characteristics of 
the 44 patients are shown in Table 1. 
Mean time on PD was 48.7 ± 32.6 months in CAPD 
and 47.5 ± 38.4 months in APD group. Primary causes 
of ESRD were diabetic nephropathy (n = 18, 40.1%), 
hypertension (n = 12, 27.3%), chronic glomerulonephritis 
(n = 7, 15.9%), and unknown etiology (n = 7, 15.9%). 
There was no significant difference in gender, age, BMI, 
body weight, primary diagnosis for ESRD, duration of 
dialysis and hypertension, use of erythropoietin, dialysate/
Table 1. Clinical Characteristics by CAPD and APD 
CAPD (n = 26) APD (n = 18) P-value
Male : Female (n) 9 : 17 7 : 11 ns
Age (year) 52.8 ± 11.9 45.7 ± 14.2 ns
BMI (kg/m2) 22.6 ± 4.0 20.9 ± 4.4 ns
Body weight (kg) 59.7 ± 11.2 61.0 ± 9.7 ns
Cause of ESRD
Diabetes, n (%) 11 (42.3) 7 (38.8) ns
Hypertension, n (%)   7 (26.9) 5 (27.7) ns
CGN, n (%)   4 (15.3) 3 (16.7) ns
Unknown, n (%)   4 (15.3) 3 (16.7) ns
Duration of dialysis (month) 48.7 ± 32.6 47.5 ± 38.4 ns
Duration of HT (month) 10.4 ± 5.2 8.8 ± 5.0 ns
Erythropoietin use, n (%)       20 (76.9)   15 (83.3) ns
D/P creatinine 0.64 ± 0.11 0.65 ± 0.09 ns
Weekly Kt/V urea 2.3 ± 0.6 2.1 ± 0.5 ns
Weekly CrCl L/1.73m
2 85.6 ± 40.0 78.0 ± 50.5 ns
Hemoglobin (g/dL) 9.9 ± 1.1 9.6 ± 2.3 ns
Hematocrit (%) 29.9 ± 3.1 30.9 ± 5.2 ns
Serum albumin (mg/dL) 3.57 ± 0.44 3.61 ± 0.33 ns
Serum calcium (mg/dL) 9.23 ± 0.96 8.99 ± 1.02 ns
Serum phosphate (mg/dL) 5.12 ± 1.50 5.17 ± 1.66 ns
CAPD, continuous ambulatory peritoneal dialysis; APD, automated 
peritoneal dialysis; BMI, body mass index; ESRD, end-stage renal 
disease; CGN, chronic gromerulonephritis; HT, hypertension; CrCl, 
creatinine clearance; ns, not significant.Electrolyte Blood Press 9:16-22, 2011 • doi: 10.5049/EBP.2011.9.1.16    19
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plasma (D/P) creatinine ratio, weekly Kt/V, weekly 
creatinine clearance, hemoglobin, hematocrit serum 
albumin, calcium, and phosphate. Only 2 patients of 18 
APD had high PET characteristics.
Thirty-six (81.8%) of the 44 PD patients were treated 
with antihypertensive agents, including angiotensin 
converting enzyme inhibitors, angiotensin receptor 
blocker, beta-blockers, calcium channel blockers, alpha-
blockers, diuretics or combinations of such medications. 
There was no significant difference in total number of 
antihypertensives between the 2 groups (Table 2). 
2. Comparison of blood pressure control between CAPD 
and APD
There were no significant differences in ambulatory mean 
systolic and diastolic blood pressure, daytime systolic and 
diastolic blood pressure, and nighttime systolic and diastolic 
blood pressure between the 2 groups (Table 3). Ambulatory 
systolic and diastolic blood pressure of 24-hour, daytime, 
and nighttime in the CAPD group were lower than those of 
the APD group, despite not reaching statistically significant 
levels. 
On analysis for diurnal variation of blood pressure, there 
was no difference in the non-dipper hypertension rate 
between 2 groups. Twenty-three of 26 (88.5%) CAPD 
patients were non-dipper, whereas 15 of 18 (83.3%) APD 
patients were non-dipper. On comparing diurnal indices of 
systolic and diastolic blood pressure between two groups, 
no difference was found in both CAPD and APD groups 
(Table 4).
Table 2. Comparison of Use of Anti-Hypertensive Agent between CAPD 
and APD
CAPD (n = 26) APD (n = 18) P-value
ACE inhibitor (n)    3   4 ns
ARB (n) 11 16 ns
β-blocker (n) 10 14 ns
CCB (n) 21 12 ns
Diuretics (n)   5   3 ns
α-blocker (n)   2   5 ns
Vasodilator (n)   1   0 ns
Anti-HTN No. 2.54 ± 1.42 3.06 ± 1.70 ns
CAPD, continuous ambulatory peritoneal dialysis; APD, automated 
peritoneal dialysis; ACE inhibitor, angiotensin converting enzyme inhibitor; 
ARB, angiotensin receptor blocker; CCB, calcium channel blocker; Anti-
HTN No., total number of antihypertensive agent; ns, not significant.
Table 3. Comparison of Blood Pressure Control between CAPD and 
APD
CAPD (n = 26) APD (n = 18) P-value
Mean SBP (mmHg)
24hr mean 139.2 ± 20.3 144.7 ± 24.7 0.51
Daytime 139.6 ± 20.0 145.7 ± 24.4 0.47
Nighttime 136.6 ± 22.5 142.1 ± 27.1 0.59
Mean DBP (mmHg)
24hr mean 85.5 ± 10.0   89.8 ± 14.1 0.25
Daytime 85.6 ± 10.8   90.6 ± 14.3 0.18
Nighttime 82.9 ± 11.4 87.89 ± 14.3 0.29
MAP (mmHg)
24hr mean 104.6 ± 12.2 109.5 ± 16.6 0.37
Daytime 105.2 ± 12.1 110.2 ± 16.5 0.29
Nighttime 102.5 ± 14.4 107.6 ± 17.4 0.41
CAPD, continuous ambulatory peritoneal dialysis; APD, automated 
peritoneal dialysis; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; MAP, mean arterial pressure.
Table 4. Comparison of Diurnal Blood Pressure Variations and 
Proportions of Non-dipper Hypertension between CAPD and APD
CAPD (n = 26) APD (n = 18) P-value
Diurnal index of SBP (%) 2.04 ± 7.45 2.64 ± 6.05 ns
Diurnal index of DBP (%) 3.07 ± 6.70 2.94 ± 5.66 ns
Non-dipper HT, n (%) 23 (88.5) 15 (83.3) ns
Diurnal index of BP calculated as the ratio between the blood pressure 
difference of daytime and nighttime and the daytime blood pressure 
value, multiplied by 100. CAPD, continuous ambulatory peritoneal 
dialysis; APD, automated peritoneal dialysis; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; HT, hypertension; ns, not significant; BP, 
blood pressure.
Table 5. Comparison of Blood Pressure Loads and Left Ventricular 
Hypetrophy between CAPD and APD
CAPD (n = 26) APD (n = 18) P-value
Systolic BP loads (%)
24hr    40.5 ± 36.7   50.4 ± 42.8 0.42
Daytime   29.1 ± 25.7   35.4 ± 28.5 0.35
Nighttime   11.3 ± 13.6   13.4 ± 15.2 0.85
Diastolic BP loads (%)
24hr   29.4 ± 32.5   44.6 ± 39.5 0.23
Daytime   21.1 ± 23.8 31.02 ± 27.9 0.26
Nighttime     8.3 ± 10.8   13.6 ± 12.5 0.12
LVMI (g/m
2) 162.7 ± 52.8 158.4 ± 40.6 0.93
CAPD, continuous ambulatory peritoneal dialysis; APD, automated 
peritoneal dialysis; BP, blood pressure; LVMI, left ventricular mass index.20      JS Jang et al. • Blood Pressure Control and LVH in Patients on CAPD and APD 
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There were no significant differences in systolic and 
diastolic blood pressure load and LVMI between CAPD 
and APD groups (Table 5).
There were no significant correlations between LVMI 
and 24-hour mean systolic and diastolic blood pressure, 
daytime systolic and diastolic blood pressure, and nighttime 
systolic and diastolic blood pressures. 
LVMI was correlated with 24-hour systolic BP load (r = 
0.311, P < 0.05) and daytime systolic BP load (r = 0.360, P 
< 0.05) (Fig. 1 and 2).
Discussion 
There is an ongoing controversy in the literature as to 
whether APD is associated with less effective control of 
blood pressure as compared with CAPD. Wang et al.
20) 
found similar levels of blood pressure in patients on CAPD 
and APD, but a higher ventricular mass in patients on APD, 
which they attributed to potential diurnal hypervolemia in 
this therapy. Ortega et al.
21) detected higher systolic blood 
pressure levels in APD than in CAPD, but were unable 
to find a correlation between sodium removal and blood 
pressure levels.
Our study demonstrates that there were no significant 
differences in blood pressure control, diurnal variation of 
blood pressure, and left ventricular mass between CAPD 
and APD. 
Left ventricular hypertrophy is a strong predictor of 
myocardial infarction, heart failure, sudden death, and 
stroke in patients with essential hypertension and in patients 
with ESRD
22-26). There are reports of a high incidence of 
LVH in CAPD patients and that LVH seemed to be strongly 
associated with a significantly high cardiovascular morbidity 
and mortality in CAPD patients
27). It has reported that each 
10 mmHg rise in average mean arterial blood pressure was 
associated with a 48% increased likelihood of having both 
concentric LVH and left ventricular dilation on second 
echocardiogram for patients with ESRD
28). However, in this 
study, we have not observed significant difference in LVMI 
between CAPD and APD groups. Ambulatory systolic and 
diastolic blood pressure at 24-hour, daytime and nighttime 
was not associated with LVMI. 
It has been reported that ambulatory nighttime systolic 
blood pressure load > 30% had an independent association 
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Fig. 1. Correlation between LVMI and 24-Hour Systolic Blood Pressure 
Load (r = 0.311, P < 0.05). LVMI, left ventricular mass index; 24hr Load 
SBP, 24 hour systolic blood pressure load.
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Fig. 2. Correlation between LVMI and Daytime Systolic Blood Pressure 
Load (r = 0.36, P < 0.05). LVMI, left ventricular mass index; Day Load 
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with LVH
20). Similarly, we found in our study that LVMI in 
patients on peritoneal dialysis correlated with 24-hour systolic 
blood pressure load and daytime systolic blood pressure load. 
Diurnal blood pressure rhythm is known to be abnormal 
in chronic renal failure, dialysis and renal transplantation 
patients. It has been reported that non-dipper patients 
have increased risk of target organ damage and mortality 
in patients with hypertension
29-31). Recently, reduced 
blood pressure diurnal variability has been reported as a 
risk factor for left ventricular dilatation in hemodialysis 
patents. Although a number of factors such as autonomic 
dysfunction, increase in plasma volume, heart failure 
and sleep disorders have been implicated for abnormal 
circadian rhythm of BP in dialysis patients, the main reason 
of it was unclear. Subjectively assessed sleep disturbance 
during overnight BP monitoring increases the nocturnal 
BP level and potentially attenuates the correlation with 
hypertension-related cardiac damage, even though habi-
tuation to overnight BP monitoring occurs
32).
It has been suggested that APD may be less effective 
than CAPD for sodium and fluid removal, due to its semi-
intermittent nature and frequently lower capacity for 
ultrafiltration, and also to the short dwell schedule that 
characterizes the night session in APD, which may result 
in significant sodium sieving and less efficient sodium 
removal
32). In addition, the alarms or noises of the APD 
machine may cause sleep disturbance in patients on APD. 
However, we found no difference in diurnal variation of 
blood pressure for APD compared with CAPD .
Recently, patients are increasingly selecting APD for 
lifestyle reasons rather than CAPD because they have 
high transport membrane characteristics, resulting in an 
increasing proportion of APD patients having low transport 
membrane characteristics. In this study, there was no 
difference in D/P creatinine and only 2 patients had high 
transporter membrane characteristics in the APD group. 
In this study, 81.8% of the peritoneal dialysis patients were 
receiving antihypertensive agents, and these medications 
themselves may affect blood pressure control and circadian 
blood pressure rhythm. 
There are limitations to this study. The size of our 
study population was not large enough to compare the 
difference between CAPD and APD group. In addition, 
we did not evaluate the sodium removal and volume status 
between CAPD and APD groups. Further study is needed 
to investigate whether the effect of the sodium and fluid 
removal according to CAPD regimen can influence the 
blood pressure control. 
It has been suggested that the use of a glucose polymeric 
solution, icodextrin 7.5%, is able to improve volume status 
in peritoneal dialysis patients due to an improved and 
prolonged ultrafiltration, especially during long dwells
33-35). 
Further study is needed to study the influence of icodextrin 
for long dwells in APD on volume status and blood pressure 
control.
In conclusion, we found no difference in blood pressure 
control, diurnal variation of blood pressure, and left 
ventricular hypertrophy for APD compared with CAPD. 
The different peritoneal dialysis regimens might not 
influence blood pressure control and diurnal variation of 
blood pressure in patients on peritoneal dialysis.
References
 1) Wilson J, Nissenson AR: Determinants in APD selection. Semin 
Dial 15:388-392, 2002
 2) Brunkhorst R, Wrenger E, Krautzig S, Ehlerding G, Mahiout A, 
Koch KM: Clinical experience with home automated peritoneal 
dialysis. Kidney Int 46(Suppl 48):S25-30, 1994
 3) Holley JL, Bernardini J, Piraino B: Continuous cycling peritoneal 
dialysis is associated with lower rates of catheter infections than 
continuous ambulatory peritoneal dialysis. Am J Kidney Dis 
16:133-136, 1990
 4) Rodriguez AM, Diaz NV, Cubillo LP, et al.: Automated peritoneal 
dialysis: a Spanish multicentre study. Nephrol Dial Transplant 
13:2335-2340, 1998
 5) Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A: 
Rapid decline of residual renal function in patients on automated 
peritoneal dialysis. Perit Dial Int 16:307-315, 1996
 6) Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri H, 
Mignon F: The influence of automated peritoneal dialysis on 
the decrease in residual renal function. Nephrol Dial Transplant 
14:1224-1228, 199922      JS Jang et al. • Blood Pressure Control and LVH in Patients on CAPD and APD 
Copyright © 2011 The Korean Society of Electrolyte Metabolism
 7) Rodriguez-Carmona A, Fontan MP: Sodium removal in patients 
undergoing CAPD and automated peritoneal dialysis. Perit Dial 
Int 22:705-713, 2002
 8) Ortega O, Gallar P, Carreno A, et al.: Peritoneal sodium mass 
removal in continuous ambulatory peritoneal dialysis and 
automated peritoneal dialysis: influence on blood pressure control. 
Am J Nephrol 21:189-193, 2001
 9) Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, 
Villaverde P, Peteiro J: Compared time profiles of ultrafiltration, 
sodium removal, and renal function in incident CAPD and 
automated peritoneal dialysis patients. Am J Kidney Dis 44:132-
145, 2004
10) Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R: 
Dietary protein requirements and dialysate protein losses in 
chronic peritoneal dialysis patients. Perit Dial Int 27:192-195, 2007
11) Erturk S, Ertug AE, Ates K, et al.: Relationship of ambulatory 
blood pressure monitoring data to echocardiographic findings in 
haemodialysis patients. Nephrol Dial Transplant 11:2050-2054, 
1996
12) Katzarski KS, Charra B, Luik AJ, et al.: Fluid state and 
blood pressure control in patients treated with long and short 
haemodialysis. Nephrol Dial Transplant 14:369-375, 1999
13) Gunal AI, Duman S, Ozkahya M, et al.: Strict volume control 
normalizes hypertension in peritoneal dialysis patients. Am J 
Kidney Dis 37:588-593, 2001
14) Phillips RA, Diamond JA: Ambulatory blood pressure monitoring 
and echocardiography--noninvasive techniques for evaluation of 
the hypertensive patient. Prog Cardiovasc Dis 41:397-440, 1999
15) Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations 
regarding quantitation in M-mode echocardiography: results of a 
survey of echocardiographic measurements. Circulation 58:1072-
1083, 1978
16) Devereux RB, Reichek N: Echocardiographic determination of 
left ventricular mass in man. Anatomic validation of the method. 
Circulation 55:613-618, 1977
17) Dubois D, Dubois EF: A formula to estimate the approximate 
surface area if height and weight be known. Arch Intern Med 
17:863-871, 1916
18) Watson PE, Watson ID, Batt RD: Total body water volumes for 
adult males and females estimated from simple anthropometric 
measurements. Am J Clin Nutr 33:27-39, 1980
19) Twardowski ZJ: Clinical value of standardized equilibration tests 
in CAPD patients. Blood Purif 7:95-108, 1989
20) Wang MC, Tseng CC, Tsai WC, Huang JJ: Blood pressure and 
left ventricular hypertrophy in patients on different peritoneal 
dialysis regimens. Perit Dial Int 21:36-42, 2001
21) Ortega O, Gallar P, Carreno A, et al.: Peritoneal sodium mass re-
moval in continuous ambulatory peritoneal dialysis and automated 
peritoneal dialysis: influence on blood pressure control. Am J 
Nephrol 21:189-193, 2001
22) Casale PN, Devereux RB, Milner M, et al.: Value of echo-
cardiographic measurement of left ventricular mass in predicting 
cardiovascular morbid events in hypertensive men. Ann Intern 
Med 105:173-178, 1986
23) Frohlich ED: Left ventricular hypertrophy as a risk factor. Cardiol 
Clin 4:137-144, 1986
24) Anderson KP: Sudden death, hypertension, and hypertrophy. J 
Cardiovasc Pharmacol 6(Suppl 3):S498-503, 1984
25) McLenachan JM, Henderson E, Morris KI, Dargie HJ: Ven-
tricular arrhythmias in patients with hypertensive left ventri  cular 
hypertrophy. N Engl J Med 317:787-792, 1987
26) Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: 
Prognostic implications of echocardiographically determined left 
ventricular mass in the Framingham Heart Study. N Engl J Med 
322:1561-1566, 1990
27) Silaruks S, Sirivongs D, Chunlertrith D: Left ventricular 
hypertrophy and clinical outcome in CAPD patients. Perit Dial 
Int 20:461-466, 2000
28) Chung JH, Yun NR, Ahn CY, Lee WS, Kim HL: Relationship 
between serum N-terminal pro-brain natriuretic peptide level and 
left ventricular dysfunction and extracellular water in continuous 
ambulatory peritoneal dialysis patients. Electrolyte Blood Press 
6:15-21, 2008
29) Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter 
H: Non-dipping circadian blood pressure and renal impairment 
are associated with increased mortality in diabetes mellitus. Diabet 
Med 17:360-364, 2000
30) White WB: How well does ambulatory blood pressure predict 
target-organ disease and clinical outcome in patients with 
hypertension? Blood Press Monit 4(Suppl 2):S17-21, 1999
31) Covic A, Goldsmith DJ, Covic M: Reduced blood pressure diurnal 
variability as a risk factor for progressive left ventricular dilatation 
in hemodialysis patients. Am J Kidney Dis 35:617-623, 2000
32) Verdecchia P, Angeli F, Borgioni C, Gattobigio R, Reboldi G: 
Ambulatory blood pressure and cardiovascular outcome in relation 
to perceived sleep deprivation. Hypertension 49:777-783, 2007
33) Struijk DG, Krediet RT: Sodium balance in automated peritoneal 
dialysis. Perit Dial Int 20(Suppl 2):S101-105, 2000
34) Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, 
Verbrugh HA: Assessment of the effectiveness, safety, and 
biocompatibility of icodextrin in automated peritoneal dialysis. 
The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial 
Int 20(Suppl 2):S106-113, 2000
35) Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent 
K: Icodextrin as salvage therapy in peritoneal dialysis patients with 
refractory fluid overload. BMC Nephrol 2:2, 2001